UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?

Transfusion (Philadelphia, Pa.), 1999-07, Vol.39 (7), p.665-670

Blajchman, M.A.

1999

Volltextzugriff (PDF)

Transfusion immunomodulation or TRIM: What does it mean clinically?

Hematology (Luxembourg), 2005-09, Vol.10 (sup1), p.208-214

Blajchman, M. A.

2005

Volltextzugriff (PDF)

Substitutes and alternatives to platelet transfusions in thrombocytopenic patients

Journal of thrombosis and haemostasis, 2003-07, Vol.1 (7), p.1637-1641

Blajchman, M. A.

2003

Volltextzugriff (PDF)

Biologic effects of leukocytes present in transfused cellular blood products

Blood, 1994-09, Vol.84 (6), p.1703-1721

1994

Volltextzugriff (PDF)

Protecting the blood supply from emerging pathogens: The role of pathogen inactivation

Transfusion clinique et biologique (Paris), 2009-05, Vol.16 (2), p.70-74

Blajchman, M.A.

2009

Volltextzugriff (PDF)

Immunomodulatory Effects of Allogeneic Blood Transfusions: Clinical Manifestations and Mechanisms

Vox sanguinis, 1998-06, Vol.74 (S2), p.315-319

Blajchman, M.A.

1998

Volltextzugriff (PDF)

Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A

Thrombosis and haemostasis, 2000-03, Vol.83 (3), p.387-391

2000

Volltextzugriff (PDF)

Incidence and significance of the bacterial contamination of blood components

Developments in biologicals, 2002, Vol.108, p.59

Blajchman, M A

2002

Volltextzugriff (PDF)

Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet?

Transfusion (Philadelphia, Pa.), 1997-02, Vol.37 (2), p.121-125

Blajchman, Morris A.

1997

Volltextzugriff (PDF)

In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days

Transfusion (Philadelphia, Pa.), 2005-06, Vol.45 (6), p.904-910

2005

Volltextzugriff (PDF)

Bacterial Contamination and Proliferation during the Storage of Cellular Blood Products

Vox sanguinis, 1998-06, Vol.74 (S2), p.155-159

Blajchman, M.A.

1998

Volltextzugriff (PDF)

A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care

The New England journal of medicine, 1999-02, Vol.340 (6), p.409-417

1999

Volltextzugriff (PDF)

Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial

Transfusion (Philadelphia, Pa.), 2005-06, Vol.45 (6), p.896-903

2005

Volltextzugriff (PDF)

Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

Blood, 2001-03, Vol.97 (5), p.1180-1195

2001

Volltextzugriff (PDF)

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?

Critical care medicine, 2001-02, Vol.29 (2), p.227-234

2001

Volltextzugriff (PDF)

RBC T activation and hemolysis: implications for pediatric transfusion management

Transfusion (Philadelphia, Pa.), 2000-07, Vol.40 (7), p.801-812

2000

Volltextzugriff (PDF)

Novel platelet products, substitutes and alternatives

Transfusion clinique et biologique (Paris), 2001-06, Vol.8 (3), p.267-271

Blajchman, M.A

2001

Volltextzugriff (PDF)

A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery

The New England journal of medicine, 2008-05, Vol.358 (22), p.2319-2331

2008

Volltextzugriff (PDF)

The top ten list of randomized controlled trials in transfusion medicine

Vox sanguinis, 2004-07, Vol.87 (s2), p.193-196

Blajchman, M. A.

2004

Volltextzugriff (PDF)

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests

The Lancet (British edition), 1995-01, Vol.345 (8941), p.21-25

1995

Volltextzugriff (PDF)

Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion : the importance of the timing of the leukodepletion

Blood, 1994-07, Vol.84 (1), p.344-348

1994

Volltextzugriff (PDF)

Reducing the risk of bacterial contamination of cellular blood components

Developments in biologicals, 2000, Vol.102, p.183

Blajchman, M A

2000

Volltextzugriff (PDF)

Allogeneic Blood Transfusion-Induced Enhancement of Tumor Growth: Two Animal Models Showing Amelioration by Leukodepletion and Passive Transfer Using Spleen Cells

Blood, 1993-04, Vol.81 (7), p.1880-1882

1993

Volltextzugriff (PDF)

The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals

British journal of haematology, 1994-02, Vol.86 (2), p.347-350

1994

Volltextzugriff (PDF)

ABO sequence analysis in a family with weak expression of blood group B

Transfusion (Philadelphia, Pa.), 2004-09, Vol.44 (9), p.1394-1395

2004

Volltextzugriff (PDF)

1 – 25 von 385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Englisch
(384)
Französisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?

Transfusion immunomodulation or TRIM: What does it mean clinically?

Substitutes and alternatives to platelet transfusions in thrombocytopenic patients

Biologic effects of leukocytes present in transfused cellular blood products

Protecting the blood supply from emerging pathogens: The role of pathogen inactivation

Immunomodulatory Effects of Allogeneic Blood Transfusions: Clinical Manifestations and Mechanisms

Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A

Incidence and significance of the bacterial contamination of blood components

Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet?

In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days

Bacterial Contamination and Proliferation during the Storage of Cellular Blood Products

A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care

Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial

Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?

RBC T activation and hemolysis: implications for pediatric transfusion management

Novel platelet products, substitutes and alternatives

A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery

The top ten list of randomized controlled trials in transfusion medicine

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests

Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion : the importance of the timing of the leukodepletion

Reducing the risk of bacterial contamination of cellular blood components

Allogeneic Blood Transfusion-Induced Enhancement of Tumor Growth: Two Animal Models Showing Amelioration by Leukodepletion and Passive Transfer Using Spleen Cells

The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals

ABO sequence analysis in a family with weak expression of blood group B

Suchergebnisse filtern